News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
258 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24193)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (183)
2 (133)
5 (258)
6 (198)
7 (182)
8 (148)
9 (107)
12 (179)
13 (165)
14 (166)
15 (167)
16 (111)
19 (154)
20 (181)
21 (149)
22 (151)
23 (144)
26 (176)
27 (154)
28 (138)
29 (167)
30 (89)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
Eisai Inc. Release: Lenvatinib Demonstrates Positive Results Vs Sorafenib Across All Endpoints In First-Line Phase III Non-Inferiority Trial Of Unresectable Hepatocellular Carcinoma (uHCC)
June 5, 2017
·
15 min read
Drug Development
Eli Lilly Builds Upon Body Of Data For Abemaciclib With Phase III MONARCH 2 Data Demonstrating Superior Progression-Free Survival In Advanced Breast Cancer
June 5, 2017
·
9 min read
Drug Development
ARMO BioSciences Announces Encouraging Survival Data Observed In Patients With Advanced Pancreatic Cancer In Phase I/Ib Trial Of Immunotherapy AM0010
June 5, 2017
·
6 min read
Drug Development
Further Study Of Combination Of Eisai Inc.'s Lenvatinib And Merck & Co.'s Pembrolizumab In Previously Treated Patients With Metastatic Endometrial Cancer Supported By Interim Analysis Of Ongoing Phase Ib/II Trial
June 5, 2017
·
16 min read
Drug Development
ARMO BioSciences Announces Promising Response Rates And Survival Data In Patients With Advanced NSCLC And RCC From Phase I/Ib Trial For Immunotherapy AM0010 With Checkpoint Inhibitors
June 5, 2017
·
7 min read
Drug Development
Amgen Presents New Phase II Data On IMLYGIC (Talimogene Laherparepvec) Investigational Combination At ASCO 2017
June 5, 2017
·
16 min read
Drug Development
Amgen Presents New Data From Phase III XGEVA (Denosumab) Study In Patients With Multiple Myeloma At ASCO 2017
June 5, 2017
·
18 min read
Drug Development
Halozyme Phase II Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO
June 5, 2017
·
6 min read
Drug Development
CARsgen Therapeutics Presents Phase I Results Of CAR-GPC3 T HCC Trial At ASCO 2017 Annual Meeting
June 5, 2017
·
2 min read
Drug Development
APHINITY Study Shows Genentech’s Perjeta-Based Regimen Reduced The Risk Of Invasive Cancer Returning Compared To Herceptin And Chemotherapy In HER2-Positive Early Breast Cancer
June 5, 2017
·
1 min read
1 of 26
Next
